<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE LIFECORE BIOMEDICAL, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE TWELVE MONTHS ENDED JUNE 30, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 12-MOS <FISCAL-YEAR-END> JUN-30-1997 <PERIOD-START> JUL-01-1996 <PERIOD-END> JUN-30-1997 <CASH> 1,371,000 <SECURITIES> 20,590,000 <RECEIVABLES> 5,078,000 <ALLOWANCES> 268,000 <INVENTORY> 10,279,000 <CURRENT-ASSETS> 32,665,000 <PP&E> 24,493,000 <DEPRECIATION> 5,483,000 <TOTAL-ASSETS> 65,509,000 <CURRENT-LIABILITIES> 5,817,000 <BONDS> 7,596,000 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 122,000 <OTHER-SE> 51,974,000 <TOTAL-LIABILITY-AND-EQUITY> 65,509,000 <SALES> 18,913,000 <TOTAL-REVENUES> 18,913,000 <CGS> 9,052,000 <TOTAL-COSTS> 12,153,000 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 641,000 <INCOME-PRETAX> (1,033,000) <INCOME-TAX> 0 <INCOME-CONTINUING> (1,033,000) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (1,033,000) <EPS-PRIMARY> (.08) <EPS-DILUTED> (.08)